BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9458298)

  • 1. Absence of mutatins in the analysis of coding sequences of the entire transforming growth factor beta type II receptor gene in sporadic humangastric cancer using genomic DNA and intron primers.
    Takenoshita S; Mogi A; Osawa H; Sunaga H; Kakegawa H; Tani M; Morinaga N; Kato R; Hagiwara K; Nagamachi Y
    Oncol Rep; 1998; 5(1):77-80. PubMed ID: 9458298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of mutations in the analysis of coding sequences of the entire transforming growth factor-beta type II receptor gene in sporadic human breast cancers.
    Takenoshita S; Mogi A; Tani M; Osawa H; Sunaga H; Kakegawa H; Yanagita Y; Koida T; Kimura M; Fujita KI; Kato H; Kato R; Nagamachi Y
    Oncol Rep; 1998; 5(2):367-71. PubMed ID: 9468559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutation analysis of coding sequences of the entire transforming growth factor beta type II receptor gene in sporadic human colon cancer using genomic DNA and intron primers.
    Takenoshita S; Tani M; Nagashima M; Hagiwara K; Bennett WP; Yokota J; Harris CC
    Oncogene; 1997 Mar; 14(10):1255-8. PubMed ID: 9121777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation of the transforming growth factor-beta type II receptor gene is a rare event in human sporadic gastric carcinomas.
    Shitara Y; Yokozaki H; Yasui W; Takenoshita S; Nagamachi Y; Tahara E
    Int J Oncol; 1998 May; 12(5):1061-5. PubMed ID: 9538129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analyses of mutation and loss of heterozygosity of coding sequences of the entire transforming growth factor beta type II receptor gene in sporadic human gastric cancer.
    Guo RJ; Wang Y; Kaneko E; Wang DY; Arai H; Hanai H; Takenoshita S; Hagiwara K; Harris CC; Sugimura H
    Carcinogenesis; 1998 Sep; 19(9):1539-44. PubMed ID: 9771922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The relationship between frameshift mutations of transforming growth factor-beta type II receptor, insulin growth factor II receptor, bcl-2 associated X protein, E2F4 and microsatellite instability in gastric carcinoma].
    Chen GT; Zhu ZG; Yin HR; Liu BY; Ji J; Zhang J; Lin YZ
    Zhonghua Wai Ke Za Zhi; 2006 Mar; 44(5):344-8. PubMed ID: 16635398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infrequent mutations of the transforming growth factor beta-type II receptor gene at chromosome 3p22 in human lung cancers with chromosome 3p deletions.
    Tani M; Takenoshita S; Kohno T; Hagiwara K; Nagamachi Y; Harris CC; Yokota J
    Carcinogenesis; 1997 May; 18(5):1119-21. PubMed ID: 9163705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation analysis of transforming growth factor beta type II receptor, Smad2, Smad3 and Smad4 in esophageal squamous cell carcinoma.
    Osawa H; Shitara Y; Shoji H; Mogi A; Kuwano H; Hagiwara K; Takenoshita S
    Int J Oncol; 2000 Oct; 17(4):723-8. PubMed ID: 10995883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational analysis of the transforming growth factor beta receptor type II gene in hereditary nonpolyposis colorectal cancer and early-onset colorectal cancer patients.
    Shin KH; Park YJ; Park JG
    Clin Cancer Res; 2000 Feb; 6(2):536-40. PubMed ID: 10690536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel missense mutation and frameshift mutations in the type II receptor of transforming growth factor-beta gene in sporadic colon cancer with microsatellite instability.
    Orimo H; Ikejima M; Nakajima E; Emi M; Shimada T
    Mutat Res; 1998 May; 382(3-4):115-20. PubMed ID: 9691992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microsatellite alterations and K-ras, TGFbetaRII, IGFRII and bax mutations in sporadic cancers of the gastrointestinal tract.
    Caligo MA; Ghimenti C; Sensi E; Marchetti A; Bertacca G; Giulianotti PG; Fornaciari G; Bevilacqua G
    Oncol Rep; 2000; 7(6):1371-5. PubMed ID: 11032947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation analysis of the transforming growth factor-beta type II receptor in human cell lines resistant to growth inhibition by transforming growth factor-beta.
    Vincent F; Nagashima M; Takenoshita S; Khan MA; Gemma A; Hagiwara K; Bennett WP
    Oncogene; 1997 Jul; 15(1):117-22. PubMed ID: 9233784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations of transforming growth factor-beta 1 receptor type II occur in ulcerative colitis-associated carcinomas, sporadic colorectal neoplasms, and esophageal carcinomas, but not in gastric neoplasms.
    Souza RF; Garrigue-Antar L; Lei J; Yin J; Appel R; Vellucci VF; Zou TT; Zhou X; Wang S; Rhyu MG; Cymes K; Chan O; Park WS; Krasna MJ; Greenwald BD; Cottrell J; Abraham JM; Simms L; Leggett B; Young J; Harpaz N; Reiss M; Meltzer SJ
    Hum Cell; 1996 Sep; 9(3):229-36. PubMed ID: 9183654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microsatellite instability and gene mutations in transforming growth factor-beta type II receptor are absent in small bowel carcinoid tumors.
    Kidd M; Eick G; Shapiro MD; Camp RL; Mane SM; Modlin IM
    Cancer; 2005 Jan; 103(2):229-36. PubMed ID: 15599934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations of the transforming growth factor-beta type II receptor gene and genomic instability in hereditary nonpolyposis colorectal cancer.
    Lu SL; Akiyama Y; Nagasaki H; Saitoh K; Yuasa Y
    Biochem Biophys Res Commun; 1995 Nov; 216(2):452-7. PubMed ID: 7488133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colorectal carcinomas and PTEN/MMAC1 gene mutations.
    Dicuonzo G; Angeletti S; Garcia-Foncillas J; Brugarolas A; Okrouzhnov Y; Santini D; Tonini G; Lorino G; De Cesaris M; Baldi A
    Clin Cancer Res; 2001 Dec; 7(12):4049-53. PubMed ID: 11751500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of TGF-beta type I receptor for mutations and polymorphisms in head and neck cancers.
    Knobloch TJ; Lynch MA; Song H; DeGroff VL; Casto BC; Adams EM; Alam KY; Lang JC; Schuller DE; Weghorst CM
    Mutat Res; 2001 Aug; 479(1-2):131-9. PubMed ID: 11470488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Birt-Hogg-DubĂ© (BHD) gene mutations in human gastric cancer with high frequency microsatellite instability.
    Jiang W; Fujii H; Matsumoto T; Ohtsuji N; Tsurumaru M; Hino O
    Cancer Lett; 2007 Apr; 248(1):103-11. PubMed ID: 16870330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RER phenotype and its associated mutations in familial gastric cancer.
    Shinmura K; Tani M; Isogaki J; Wang Y; Sugimura H; Yokota J
    Carcinogenesis; 1998 Feb; 19(2):247-51. PubMed ID: 9498272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infrequent frameshift mutations of polynucleotide repeats in multiple primary cancers affecting the esophagus and other organs.
    Iwaya T; Maesawa C; Nishizuka S; Suzuki Y; Sakata K; Sato N; Ikeda K; Koeda K; Ogasawara S; Otsuka K; Kimura Y; Aoki K; Ishida K; Saito K; Tamura G
    Genes Chromosomes Cancer; 1998 Dec; 23(4):317-22. PubMed ID: 9824204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.